Reinhard Kandera, Hookipa´s Chief Financial Officer (CFO), works with other senior managers to forecast and lead various funding initiatives. Reinhard has more than 20 years’ experience in the finance and healthcare industries. Immediately prior to joining Hookipa, he was a member of the Management Board and CFO of Valneva SE, a commercial-stage biotech company listed on the Euronext Paris and the Vienna Stock Exchange. Before joining Valneva, he was the CFO and a member of the Management Board of Intercell AG, another publicly-listed European biotech company, which merged with Vivalis SA to become Valneva in 2013. Reinhard Kandera held various other positions at Intercell before becoming CFO, including Global Head of Finance and Investor Relations, and CFO of Intercell USA (the formerly NASDAQ-listed Iomai Corporation). Reinhard played a pivotal role in the IPO of Intercell in 2005. He also completed many public and private financing rounds, raising hundreds of millions of euros/dollars. He also completed the acquisition and integration of businesses in Scotland, the USA, Switzerland and Sweden as well as the European cross-border merger that created Valneva. Reinhard Kandera started his career in the finance industry at Deutsche Bank AG where he held positions of increasing responsibility. He holds doctorate degrees in Business Administration and in Law from the Vienna University of Economics and Business, and the Vienna University’s Faculty of Law, respectively.